alexa Bleeding Disorders | Belgium| PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Relevant Topics

Bleeding Disorders

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • Bleeding Disorders

    Bleeding disorder is a set of disorders, or disease which normally affect the process of clotting of our blood. This bleeding can be in many cases like during an accident, trauma condition, surgery, injury or a menstrual cycle. These bleeding disorders are not only associated with bloods leaving out from our body, rather it can also be an internal bleeding beneath our skin or brain. These may be hemophilia A and B or Willebrand’s disease for example. Sometimes this disease is also termed as royal disease.
  • Bleeding Disorders

    The main symptom of bleeding disorder would be excessive bleeding and prolonged clotting time during normal injuries also. These can also easily identified by frequent nose bleeding, heavy menstrual bleeding and unexplained bruishing.
  • Bleeding Disorders

    There are mainly two common type of instant treatment available for bleeding disorder, which is iron supplementation or clotting factor repalacement and blood transfusion. These are the therapeutic aspect, but extended research is in progress in various countries, where this disease has a greater prevalence rate.
  • Bleeding Disorders

    Until now, the only available information on the worldwide prevalence of RBDs could be derived from the RBDD and the WFH global survey.The 2008 WFH survey included data from 108 countries including belgium and showed that FVII and FXI deficiencies are the most common RBDs (34% and 32%, respectively), followed by the deficiencies of fibrinogen, FV and FX (7.5%?8%) and FXIII (6%), with the rarest disorders being FII and combined FV + FVIII deficiencies (2?2.5%; Global_Survey_Report.pdf). Our analyses confirm these results. We have classified RBDs on the basis of clinical bleeding severity using expert opinion, and we report clear associations between coagulation factor activity levels and clinical bleeding severity that differ by the deficient protein.

Expert PPTs

Speaker PPTs


High Impact List of Articles

Conference Proceedings